• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COV 11.1% 16.0¢

CLEO DIAGNOSTICS LTD

Cleo Diagnostics Ltd is an Australia-based medical diagnostics company. The Company is... Cleo Diagnostics Ltd is an Australia-based medical diagnostics company. The Company is focussed on the development of non-invasive blood based In vitro diagnostics (IVD) tests to detect the presence, and recurrence, of ovarian cancer. The Company has developed a three-phased product development strategy that will deliver three related tests for ovarian cancer detection: Triage Test, Recurrence Test, and Screening Test. Triage Test is a pre-surgical test to determine the likelihood that a pre-surgical ovarian mass in a patient not yet referred to an oncologist, is malignant. Recurrence Test is a post-surgical test to identify whether a cancer is recurring following surgical removal and chemotherapy of a primary tumour. Screening Test is a screening test to identify early-stage ovarian cancer in women who do not present any symptoms consistent with ovarian cancer. The Company also offers the CLEO Test Kit, which is designed to detect a novel protein biomarker, CXCL10 in the blood.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
COV 29/04/24 0 143
29/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  143 
COV 11/04/24 1 502
11/04/24 Last post  Investie Comments Created with Sketch.  1  Views Created with Sketch.  502 
COV 02/04/24 2 713
02/04/24 Last post  Drake99 Comments Created with Sketch.  2  Views Created with Sketch.  713 
COV
News: COV Cleo Diagnostics Appoints Hcfocus To Support Commencement Of Its U.S. Market Access...
02/04/24 0 90
02/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  90 
COV 25/03/24 1 461
25/03/24 Last post  Investie Comments Created with Sketch.  1  Views Created with Sketch.  461 
COV 22/03/24 1 417
22/03/24 Last post  Investie Comments Created with Sketch.  1  Views Created with Sketch.  417 
COV 23/02/24 3 1.7K
23/02/24 Last post  Investie Comments Created with Sketch.  3  Views Created with Sketch.  1.7K 
COV 20/02/24 2 802
20/02/24 Last post  Drake99 Comments Created with Sketch.  2  Views Created with Sketch.  802 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly activities and cashflow report
29 Apr 10:10
 
COV Appoints CRO to Manage US Ovarian Cancer Clinical Trials
11 Apr 09:31
 
CLEO Appoints Partner to Commence U.S. Market Access Program
02 Apr 12:11
 
Peer-Review Supports CLEOs Ovarian Cancer Detection Tech
25 Mar 09:45
 
Appendix 4D and Half Yearly Accounts
29 Feb 17:20
 
Corporate Presentation February 2024
20 Feb 09:48
 
View More arrow Created with Sketch.
(20min delay)
Last
16.0¢
Change
-0.020(11.1%)
Mkt cap ! $11.85M
Open High Low Value Volume
18.0¢ 18.0¢ 16.0¢ $20.77K 115.9K

Buyers (Bids)

No. Vol. Price($)
2 54881 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 31542 1
View Market Depth
Last trade - 14.44pm 03/05/2024 (20 minute delay) ?
COV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.